Indications and uses
Indications: For the temporary relief of: Minor urinary discomfort Pain and burning upon urination Urinary urgency.
Solidago Compositum
- Manufacturer
- Heel Inc
- Effective date
- 2012-05-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:46
Label at a glance#
ProductSolidago Compositum
Active ingredientSOLIDAGO VIRGAUREA FLOWERING TOP, BAPTISIA TINCTORIA ROOT, BERBERIS VULGARIS ROOT BARK, EQUISETUM HYEMALE, SILVER NITRATE, LYTTA VESICATORIA, CAPSICUM, CUPRIC SULFATE, CLERODENDRANTHUS SPICATUS LEAF, CHONDRODENDRON TOMENTOSUM ROOT, SMILAX REGELII ROOT, TURPENTINE OIL, APIS MELLIFERA VENOM, AGATHOSMA BETULINA LEAF, HUMAN COXSACKIEVIRUS A, MERCURIC CHLORIDE, SUS SCROFA URINARY BLADDER, CALCIUM SULFIDE, SODIUM PYRUVATE, SUS SCROFA RENAL PELVIS, SUS SCROFA URETER, SUS SCROFA URETHRA, ESCHERICHIA COLI, ARSENIC TRIOXIDE
Label structure8 sections
Dosage and administration
Dosasge: Adults and children above 6 years: In general 1 vial 1 - 3 times daily, or as directed by a physician. Children up to 6 years: 1/2 the adult dosage. Discard unused solution.
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS
Active ingredients: Each 2.2 ml contains: Solidago virgaurea 3X, Baptisia tinctoria 4X, Berberis vulgaris 4X, Equisetum hyemale 4X, Argentum nitricum 6X, Cantharis 6X, Capsicum annuum 6X, Cuprum sulphuricum 6X, Orthosiphon stamineus 6X, Pareira brava 6X, Sarsaparilla 6X, Terebinthina 6X, Apis venenum purum 8X, Barosoma 8X, Coxsackie virus-A9 8X, Mercurius corrosivus 8X, Vesica urinaria suis 8X, Hepar sulphuris calcareum 10X, Natrum pyruvicum 10X, Pyelon suis 10X, Ureter suis 10X, Urethra suis 10X, Colibacillinum 13X, Arsenicum album 28X 22 mcl each.
PURPOSE
Minor urinary discomfort, Pain and burning upon urination, Urinary urgency
KEEP OUT OF REACH OF CHILDREN
Keep this and all medicines out of the reach of children.
INDICATIONS AND USAGE
Indications: For the temporary relief of:
- Minor urinary discomfort
- Pain and burning upon urination
- Urinary urgency.
WARNINGS
Warnings: If symptoms persist or worsen, a health care professional should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advise of a health care professional before using this product.
DOSAGE AND ADMINISTRATION
Dosasge: Adults and children above 6 years: In general 1 vial 1 - 3 times daily, or as directed by a physician. Children up to 6 years: 1/2 the adult dosage. Discard unused solution.
INACTIVE INGREDIENTS
Inactive ingredients: Isotonic sodium chloride solution
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50114-0110-6 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c4bb-f6ea-e053-dbdaa90aa703 | Solidago Compositum 2.2ml Oral Vial |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50114-0110-6 | Solidago Compositum | 2.2 mL in 1 VIAL | SOLUTION | 2.2 | 1 | |
| 50114-0110-6 | Solidago Compositum | 10 in 1 CARTON | SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50114-0110 | SOLIDAGO COMPOSITUM (SOLIDAGO VIRGAUREA FLOWERING TOP AND BAPTISIA TINCTORIA ROOT AND BERBERIS VULGARIS ROOT BARK AND EQUISETUM HYEMALE AND SILVER NITRATE AND LYTTA VESICATORIA AND CAPSICUM AND CUPRIC SULFATE AND CLERODENDRANTHUS SPICATUS LEAF AND CHONDRODENDRON TOMENTOSUM ROOT AND SMILAX REGELII ROOT AND TURPENTINE OIL AND APIS MELLIFERA VENOM AND AGATHOSMA BETULINA LEAF AND HUMAN COXSACKIEVIRUS A AND MERCURIC CHLORIDE AND SUS SCROFA URINARY BLADDER AND CALCIUM SULFIDE AND SODIUM PYRUVATE) SOLUTION [HEEL INC] | 1 | Legacy NDC, 2 package rows | 20120514_e1d55fd9-40fd-4a8d-8d5f-6fa721bf45fd.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AGATHOSMA BETULINA LEAF | ACTIVE INGREDIENT | 369DDH39Z0 | 1 | |
| APIS MELLIFERA VENOM | ACTIVE INGREDIENT | 76013O881M | 1 | |
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| BAPTISIA TINCTORIA ROOT | ACTIVE INGREDIENT | 5EF0HWI5WU | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE INGREDIENT | 1TH8Q20J0U | 1 | |
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 1 | |
| CAPSICUM | ACTIVE INGREDIENT | 00UK7646FG | 1 | |
| CHONDRODENDRON TOMENTOSUM ROOT | ACTIVE INGREDIENT | 395A3P448Z | 1 | |
| CLERODENDRANTHUS SPICATUS LEAF | ACTIVE INGREDIENT | DSS8V86H3Y | 1 | |
| CUPRIC SULFATE | ACTIVE INGREDIENT | LRX7AJ16DT | 1 | |
| EQUISETUM HYEMALE | ACTIVE INGREDIENT | 59677RXH25 | 1 | |
| ESCHERICHIA COLI | ACTIVE INGREDIENT | 514B9K0L10 | 1 | |
| HUMAN COXSACKIEVIRUS A | ACTIVE INGREDIENT | 6F61V9UVRC | 1 | |
| LYTTA VESICATORIA | ACTIVE INGREDIENT | 3Q034RO3BT | 1 | |
| MERCURIC CHLORIDE | ACTIVE INGREDIENT | 53GH7MZT1R | 1 | |
| SILVER NITRATE | ACTIVE INGREDIENT | 95IT3W8JZE | 1 | |
| SMILAX REGELII ROOT | ACTIVE INGREDIENT | 2H1576D5WG | 1 | |
| SODIUM PYRUVATE | ACTIVE INGREDIENT | POD38AIF08 | 1 | |
| SOLIDAGO VIRGAUREA FLOWERING TOP | ACTIVE INGREDIENT | 5405K23S50 | 1 | |
| SUS SCROFA RENAL PELVIS | ACTIVE INGREDIENT | CH3YJ6606V | 1 | |
| SUS SCROFA URETER | ACTIVE INGREDIENT | 7PGE2DJ8QM | 1 | |
| SUS SCROFA URETHRA | ACTIVE INGREDIENT | 799ZL63XM1 | 1 | |
| SUS SCROFA URINARY BLADDER | ACTIVE INGREDIENT | 3G7U72W8DA | 1 | |
| TURPENTINE OIL | ACTIVE INGREDIENT | C5H0QJ6V7F | 1 | |
| AGATHOSMA BETULINA LEAF | ACTIVE MOIETY | 369DDH39Z0 | 1 | |
| APIS MELLIFERA VENOM | ACTIVE MOIETY | 76013O881M | 1 | |
| ARSENIC TRIOXIDE | ACTIVE MOIETY | S7V92P67HO | 1 | |
| BAPTISIA TINCTORIA ROOT | ACTIVE MOIETY | 5EF0HWI5WU | 1 | |
| BERBERIS VULGARIS ROOT BARK | ACTIVE MOIETY | 1TH8Q20J0U | 1 | |
| CAPSICUM | ACTIVE MOIETY | 00UK7646FG | 1 | |
| CHONDRODENDRON TOMENTOSUM ROOT | ACTIVE MOIETY | 395A3P448Z | 1 | |
| CLERODENDRANTHUS SPICATUS LEAF | ACTIVE MOIETY | DSS8V86H3Y | 1 | |
| EQUISETUM HYEMALE | ACTIVE MOIETY | 59677RXH25 | 1 | |
| ESCHERICHIA COLI | ACTIVE MOIETY | 514B9K0L10 | 1 | |
| HUMAN COXSACKIEVIRUS A | ACTIVE MOIETY | 6F61V9UVRC | 1 | |
| LYTTA VESICATORIA | ACTIVE MOIETY | 3Q034RO3BT | 1 | |
| MERCURIC CATION | ACTIVE MOIETY | ED30FJ8Y42 | 1 | |
| NITRATE ION | ACTIVE MOIETY | T93E9Y2844 | 1 | |
| SMILAX REGELII ROOT | ACTIVE MOIETY | 2H1576D5WG | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| SOLIDAGO VIRGAUREA FLOWERING TOP | ACTIVE MOIETY | 5405K23S50 | 1 | |
| SULFATE ION | ACTIVE MOIETY | 7IS9N8KPMG | 1 | |
| SULFIDE ION | ACTIVE MOIETY | G15I91XETI | 1 | |
| SUS SCROFA RENAL PELVIS | ACTIVE MOIETY | CH3YJ6606V | 1 | |
| SUS SCROFA URETER | ACTIVE MOIETY | 7PGE2DJ8QM | 1 | |
| SUS SCROFA URETHRA | ACTIVE MOIETY | 799ZL63XM1 | 1 | |
| SUS SCROFA URINARY BLADDER | ACTIVE MOIETY | 3G7U72W8DA | 1 | |
| TURPENTINE OIL | ACTIVE MOIETY | C5H0QJ6V7F | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 |
Products#
Every source-derived product name is available through these pages.
- Solidago Compositum
- SOLIDAGO VIRGAUREA FLOWERING TOP and BAPTISIA TINCTORIA ROOT and BERBERIS VULGARIS ROOT BARK and EQUISETUM HYEMALE and SILVER NITRATE and LYTTA VESICATORIA and CAPSICUM and CUPRIC SULFATE and CLERODENDRANTHUS SPICATUS LEAF and CHONDRODENDRON TOMENTOSUM ROOT and SMILAX REGELII ROOT and TURPENTINE OIL and APIS MELLIFERA VENOM and AGATHOSMA BETULINA LEAF and HUMAN COXSACKIEVIRUS A and MERCURIC CHLORIDE and SUS SCROFA URINARY BLADDER and CALCIUM SULFIDE and SODIUM PYRUVATE
- SOLIDAGO VIRGAUREA FLOWERING TOP
- SODIUM CHLORIDE
- BAPTISIA TINCTORIA ROOT
- BERBERIS VULGARIS ROOT BARK
- EQUISETUM HYEMALE
- SILVER NITRATE
- NITRATE ION
- LYTTA VESICATORIA
- CAPSICUM
- CUPRIC SULFATE
- CUPRIC CATION
- SULFATE ION
- CLERODENDRANTHUS SPICATUS LEAF
- CHONDRODENDRON TOMENTOSUM ROOT
- SMILAX REGELII ROOT
- TURPENTINE OIL
- APIS MELLIFERA VENOM
- AGATHOSMA BETULINA LEAF
- HUMAN COXSACKIEVIRUS A
- MERCURIC CHLORIDE
- MERCURIC CATION
- SUS SCROFA URINARY BLADDER
- CALCIUM SULFIDE
- CALCIUM CATION
- SULFIDE ION
- SODIUM PYRUVATE
- SODIUM CATION
- SUS SCROFA RENAL PELVIS
- SUS SCROFA URETER
- SUS SCROFA URETHRA
- ESCHERICHIA COLI
- ARSENIC TRIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 50114-0110 | 50114-0110-6 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / AURICULAR (OTIC) | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / TOPICAL | 0.23 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / NASAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAVENOUS | 2916 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRA-ARTERIAL | 278 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 11 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / RECTAL | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INHALANT / RESPIRATORY (INHALATION) | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ELIXIR / ORAL | 1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / SUBCUTANEOUS | 0.7 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ENDOTRACHEAL | 7.6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAVITARY | 0.82 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / TOPICAL | 0.18 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / TOPICAL | 3.1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / RETROBULBAR | 648 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY / NASAL | 30 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | TABLET, FILM COATED / ORAL | 100 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAUDAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE / ORAL | 6 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVENOUS | 90 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUPPOSITORY / RECTAL | 140 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / RESPIRATORY (INHALATION) | 43 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | 1.35 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / IONTOPHORESIS | 3.1 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | 210 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATUMOR | 1.2 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ENDOTRACHEAL | 46.76 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cdc6114c-1b6f-4329-a612-fdc1535b6c06 | e1d55fd9-40fd-4a8d-8d5f-6fa721bf45fd | 2012-05-10 | Warnings | cdc6114c-1b6f-4329-a612-fdc1535b6c06 e1d55fd9-40fd-4a8d-8d5f-6fa721bf45fd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.